Buscar resultados de ensayos clínicos
Polycystic Kidney Diseases - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Early-Stage Polycystic Kidney Disease Biomarkers Repository Study Condición: Polycystic Kidney Disease Fecha: 2016-10-10 |
Recruiting |
Nombre del estudio: Polycystic Kidney Disease Data Repository Condición: Polycystic Kidney Disease Fecha: 2008-11-14 |
Withdrawn |
Nombre del estudio: Repository Study of Autosomal Dominant Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2013-11-07 |
Enrolling by invitation |
Nombre del estudio: Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2014-09-25 Intervenciones: Drug: Tolvaptan (OPC-41061) Tolvaptan tablets (15 or 30 mg) will be self-administered orally as split-do |
Recruiting |
Nombre del estudio: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) Condición: Polycystic Kidney Disease Fecha: 2015-09-21 Intervenciones:
|
Completed |
Nombre del estudio: Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease Condición: Polycystic Kidney Disease Fecha: 2014-05-14 Intervenciones: Dietary Supplement: Niacinamide Other Name: Vitamin B3 |
Completed |
Nombre del estudio: Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condición: Polycystic Kidney Diseases Fecha: 2006-02-01 Intervenciones: Drug: Rapamune Group 1- doses of Rapamune aimed at maintaining trough levels 5-8ng/ml Group 2 - doses of |
Recruiting |
Nombre del estudio: Lanreotide In Polycystic Kidney Disease Study Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD Fecha: 2014-04-02 Intervenciones:
|
Completed |
Nombre del estudio: Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2007-12-31 Intervenciones: Drug: Tetracosactin 1 microgram tetracosactin, intravenous injection, once for the test |
Enrolling by invitation |
Nombre del estudio: Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2009-12-23 |